JP2003325168A - Closed type cell culture system - Google Patents

Closed type cell culture system

Info

Publication number
JP2003325168A
JP2003325168A JP2003037143A JP2003037143A JP2003325168A JP 2003325168 A JP2003325168 A JP 2003325168A JP 2003037143 A JP2003037143 A JP 2003037143A JP 2003037143 A JP2003037143 A JP 2003037143A JP 2003325168 A JP2003325168 A JP 2003325168A
Authority
JP
Japan
Prior art keywords
cell culture
closed
tissue
culture system
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003037143A
Other languages
Japanese (ja)
Other versions
JP4067419B2 (en
Inventor
Shigeki Suzuki
茂樹 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Next KK
Original Assignee
Next KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Next KK filed Critical Next KK
Priority to JP2003037143A priority Critical patent/JP4067419B2/en
Publication of JP2003325168A publication Critical patent/JP2003325168A/en
Application granted granted Critical
Publication of JP4067419B2 publication Critical patent/JP4067419B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a tissue cell culture system for efficiently early proliferating a cell tissue in a damaged portion, namely in vivo, in regenerative medical engineering and for avoiding the outbreak of an infectious disease caused by bacteria in the damaged portion during a treatment. <P>SOLUTION: This closed type cell culture system is characterized by closing a tissue-lacked portion on the surface of the body or in the body to form the closed environment for preventing the invasion of bacteria and the like and circulating a solution suitable for the culture of cells in the closed tissue-lacked portion. A method for administering a medicine for promoting the cure of the tissue-lacked portion comprises utilizing the closed type cell culture system and dissolving the medicine in a perfusion liquid. <P>COPYRIGHT: (C)2004,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、損傷部位の細胞組
織を生体内(in−vivo)で増殖させ、損傷部位の
組織再生を誘導させるシステムに関する。
TECHNICAL FIELD The present invention relates to a system for inducing tissue regeneration at a damaged site by proliferating cell tissue at the damaged site in vivo.

【0002】[0002]

【従来の技術】従来から体損傷部の治療に際しては、損
傷部における異物等の不要物を除去した後に、消毒剤等
で消毒を行い、治療に適した創傷被覆剤等を損傷部に被
覆し、細胞増殖による皮膚の自己再生を図っている。し
かしながら、皮膚の自己再生では治癒に時間がかかるこ
とや、創傷部での感染症の発生等、種々の克服できない
困難な問題が存在する。
2. Description of the Related Art Conventionally, in the treatment of a body-damaged area, unnecessary substances such as foreign substances in the damaged area are removed and then disinfected with a disinfectant, etc. , We are trying to regenerate the skin by cell proliferation. However, self-renewal of the skin has various insurmountable and difficult problems such as the time required for healing and the occurrence of infections in the wound.

【0003】かかる問題点を解決するために、近年再生
医工学として、損傷部の近傍の細胞を採取して生体外
(in vitro)で増殖させて、体外で目的とする
組織や臓器を再構築し、それを欠損部に戻す方法、すな
わち培養による自家組織移植方法が行われている。例え
ば、細胞増殖用培地の容器と創傷被覆材システムとを含
む細胞培養システムに関するもの(例えば、特許文献1
参照)、創傷治療に有効な産生物質とヒト繊維芽細胞と
を含む培養皮膚代替物に関するもの(例えば、特許文献
2参照)、等がある。これらの方法は、いずれも平面的
な組織に対する方法としては有効なものであるが、多層
細胞(例えば、表皮細胞と真皮細胞の多層細胞)の培養
が困難なこと、また細胞の増殖速度が遅いことなど、解
決しなければならない問題が種々残っている。
In order to solve such a problem, in recent years, as regenerative medical engineering, cells near the injured part are collected and proliferated in vitro to reconstruct a target tissue or organ outside the body. Then, a method of returning it to the defective portion, that is, a method of transplanting an autologous tissue by culture is performed. For example, a cell culture system including a container for cell growth medium and a wound dressing system (see, for example, Patent Document 1).
), A cultured skin substitute containing a human fibroblast and a production substance effective for wound treatment (see, for example, Patent Document 2), and the like. All of these methods are effective as methods for planar tissues, but it is difficult to culture multi-layer cells (for example, multi-layer cells of epidermal cells and dermal cells), and the cell growth rate is slow. There are various problems that must be solved.

【0004】さらに、厚い組織については、生体内細胞
とは組織構造が異なることや、血管が欠如しているた
め、酸素あるいは栄養補給の困難さから、細胞の生着率
はそれほど高いものとはいえない状況である。加えて、
複雑な三次元の立体構造を有する組織、損傷部では困難
なものであり、また、処置中における感染症の発生を回
避することはできず、従来問題とされている点をいまだ
解決するものとはなっていないのが現状である。
Further, thick tissues have a different tissue structure from cells in vivo, and lack of blood vessels, which makes it difficult to supplement oxygen or nutrients, so that the survival rate of cells is not so high. I can't say that. in addition,
Tissues having a complicated three-dimensional structure, it is difficult for damaged areas, and the occurrence of infectious diseases during treatment cannot be avoided, and it is possible to solve the problems that have been encountered in the past. The current situation is that it is not.

【0005】[0005]

【特許文献1】特表2001−507218号公報[Patent Document 1] Japanese Patent Publication No. 2001-507218

【特許文献2】特開2002−200161号公報[Patent Document 2] Japanese Patent Laid-Open No. 2002-200161

【0006】[0006]

【発明が解決しようとする課題】したがって本発明は、
上記の現状に鑑み、再生医工学において、損傷部、すな
わちin vivoで効率的な細胞組織の早期の増殖を
行うと共に、処置中において損傷部での細菌による感染
症の発生を回避した組織細胞培養システムを提供するこ
とを課題とする。
Therefore, the present invention is
In view of the above-mentioned present situation, in regeneration engineering, tissue cell culture in which early generation of injured cells, that is, efficient in vivo tissue in vivo, is avoided and bacterial infection in the injured cells is avoided during treatment. The challenge is to provide a system.

【0007】かかる課題を解決するために、本発明者は
鋭意検討を加えた結果、欠損損傷部の傷口において、壊
死組織等の不要物を除去した後、細胞増殖の足場となる
生体吸収性材料を欠損スペースに埋植して、欠損部を外
部から閉鎖させると共に、その閉鎖部分へ細胞培養に適
した溶液を循環させれば、その場で効率的に欠損部組織
の再生を行うことができることに着目し、本発明を完成
させるに至った。
In order to solve such a problem, the present inventor has conducted diligent studies, and as a result, after removing unnecessary substances such as necrotic tissue at the wound of the defect damage portion, a bioabsorbable material that becomes a scaffold for cell proliferation. It is possible to efficiently regenerate the defect tissue on the spot by embedding cells in the defect space, closing the defect part from the outside, and circulating a solution suitable for cell culture to the closed part. Focusing on, the present invention has been completed.

【0008】[0008]

【課題を解決するための手段】したがって、本発明の基
本的な態様である請求項1に記載の発明は、体表面もし
くは体内の組織欠損部を外部から密閉することにより細
菌等の侵入を防御した閉鎖環境となし、当該閉鎖した組
織欠損部へ細胞培養に適した溶液を循環させることによ
り欠損部組織の再生を行うことを特徴とする閉鎖型細胞
培養システムである。
Therefore, according to the invention of claim 1 which is a basic aspect of the present invention, the invasion of bacteria and the like is prevented by sealing the body surface or the tissue defect portion in the body from the outside. The closed cell culture system is characterized in that the closed tissue is regenerated by circulating a solution suitable for cell culture into the closed tissue defect portion.

【0009】すなわち本発明は、欠損部そのものを外部
から密閉することによる閉鎖型の溶液灌流部とし、細菌
からの感染を防御し、その部分へ細胞培養に適した溶液
を循環させること、また灌流液の成分を適宜変えること
により、殺菌、細胞培養を連続して行える点に特徴を有
するものである。
That is, the present invention provides a closed-type solution perfusion part by sealing the defective part itself from the outside to prevent infection from bacteria and to circulate a solution suitable for cell culture to that part. The feature is that sterilization and cell culture can be continuously performed by appropriately changing the components of the liquid.

【0010】また、一般的に細胞はある表面に接着する
ことにより分裂して増殖していくことより、細胞増殖に
は細胞が接着する足場が必要となる。本発明において
は、かかる足場として、欠損部に生体吸収性材料を埋植
して、細胞増殖を促進させたものである。したがって請
求項2に記載の本発明は、請求項1に記載の発明におい
て、閉鎖環境内に生体吸収性材料を埋植して、欠損部組
織細胞の再生を促進させる閉鎖型細胞培養システムであ
る。
Further, since cells generally divide and grow by adhering to a certain surface, a cell attachment scaffold is required for cell growth. In the present invention, such a scaffold is one in which a bioabsorbable material is embedded in the defect portion to promote cell growth. Therefore, the present invention according to claim 2 is the closed cell culture system according to the invention according to claim 1, wherein the bioabsorbable material is embedded in a closed environment to promote regeneration of defective tissue cells. .

【0011】このような細胞増殖の足場となる生体吸収
性材料としては、例えば、ポリグリコール酸繊維、乳酸
グリコール酸共重合体繊維あるいはスポンジ、グリコー
ル酸カプロラクトン共重合体繊維、ポリ乳酸繊維あるい
はスポンジ、乳酸カプロラクトン共重合体、ポリカプロ
ラクトン繊維、ポリジオキサン繊維、コラーゲン繊維あ
るいはスポンジ、ゼラチンスポンジ、フィブリン繊維ス
ポンジ、多糖類繊維あるいはスポンジ、リン酸三カルシ
ウム多孔体ビーズ、炭酸カルシウム多孔体ビーズ、ハイ
ドロキシアパタイト等を挙げることができる。
Examples of the bioabsorbable material serving as a scaffold for cell proliferation include polyglycolic acid fiber, lactic acid glycolic acid copolymer fiber or sponge, glycolic acid caprolactone copolymer fiber, polylactic acid fiber or sponge, Lactic acid caprolactone copolymer, polycaprolactone fiber, polydioxane fiber, collagen fiber or sponge, gelatin sponge, fibrin fiber sponge, polysaccharide fiber or sponge, tricalcium phosphate porous beads, calcium carbonate porous beads, hydroxyapatite, etc. Can be mentioned.

【0012】本発明の閉鎖型細胞培養システムでは、閉
鎖環境内における細胞培養には、かかる細胞増殖が効果
的に行われるように、細胞増殖に適した溶液が灌流され
る。したがって請求項3に記載の本発明は、請求項1ま
たは2に記載の発明において、細胞培養に適した溶液
が、自己血から分離した血漿溶液血清、血小板濃厚血
清、血漿液製剤、血小板濃厚血清、血漿分画製剤、血血
液蛋白分画成分溶液、プラズマエキスパンダー、浸透圧
等張輸液、細胞培養培地である閉鎖型細胞培養システム
である。
In the closed cell culture system of the present invention, the cell culture in a closed environment is perfused with a solution suitable for cell growth so that such cell growth is effectively performed. Therefore, the present invention according to claim 3 is the invention according to claim 1 or 2, wherein the solution suitable for cell culture is plasma solution serum separated from autologous blood, platelet concentrated serum, plasma liquid preparation, platelet concentrated serum. A closed cell culture system which is a plasma fractionation preparation, a blood blood protein fractionation component solution, a plasma expander, an osmotic isotonic infusion solution, and a cell culture medium.

【0013】さらに請求項4に記載の本発明は、循環さ
せる溶液成分を治療段階ごとに変化させることにより、
欠損部の鎮痛、消毒、各再生目的組織にとって適した細
胞増殖環境を構築し、プログラム化された閉鎖型細胞培
養システムである。すなわち、欠損部における細胞培養
を有効的に行うためには、細胞増殖のための閉鎖環境を
最も効果的なものに設定する必要がある。したがって、
請求項4に記載の本発明は、かかる要求に対応でき、欠
損部の鎮痛、消毒、各再生目的組織にとって適した細胞
増殖環境を容易に構築し得るようにした点に特徴を有す
るものである。
The present invention according to claim 4 further comprises changing the circulating solution component for each treatment step.
It is a closed cell culture system that is programmed and has a cell proliferation environment suitable for analgesia of the defect, disinfection, and each tissue for regeneration. That is, in order to effectively perform cell culture in the defective portion, it is necessary to set the closed environment for cell growth to the most effective one. Therefore,
The present invention according to claim 4 is characterized in that it can meet such demands and can easily construct a cell proliferation environment suitable for analgesia and sterilization of a defective portion and each regeneration target tissue. .

【0014】また、細胞の培養環境は、細胞の培養に伴
いそのpH値、炭酸ガス分圧、酸素分圧が種々変化す
る。したがって、細胞培養に適した溶液の組成を循環さ
せるとしても、閉鎖環境は、常に細胞培養に最適な環境
にしておかなければならない。そのためには、センサー
で閉鎖環境の培養液内の物理的要因、すなわちpH値、
炭酸ガス分圧、酸素分圧をモニターし、その信号により
培養環境の入口側に設けたガス交換器を制御し、リアル
タイムで培養液の変化に合せて閉鎖環境のガス分圧の調
整をおこない、細胞培養環境を最適化しておくのが好ま
しい。そのための請求項5に記載の本発明は、閉鎖環境
の入口サイドに、閉鎖環境のpH値、炭酸ガス分圧、酸
素分圧を測定するモニター装置を具備したガス交換装置
を組み込み、モニター装置からの信号に基づき、ガス濃
度を自動調整して細胞培養環境を最適化する閉鎖型細胞
培養システムである。
The pH value, the carbon dioxide partial pressure, and the oxygen partial pressure of the cell culture environment change variously with the cell culture. Therefore, even if the composition of the solution suitable for cell culture is circulated, the closed environment must always be optimal for cell culture. To do so, the sensor is a physical factor in the culture medium in a closed environment, namely the pH value,
The carbon dioxide partial pressure and oxygen partial pressure are monitored, the gas exchanger provided at the inlet side of the culture environment is controlled by the signal, and the gas partial pressure of the closed environment is adjusted in real time according to the change of the culture solution. It is preferable to optimize the cell culture environment. Therefore, the present invention according to claim 5 incorporates a gas exchange device equipped with a monitoring device for measuring the pH value, the carbon dioxide gas partial pressure, and the oxygen partial pressure of the closed environment on the inlet side of the closed environment. It is a closed cell culture system that automatically adjusts the gas concentration based on the signal of to optimize the cell culture environment.

【0015】また、請求項6に記載の本発明は、閉鎖環
境内の圧力を持続的あるいは間欠的に制御させた閉鎖型
細胞培養システムである。すなわち、閉鎖環境内の圧力
を、たとえば圧力維持装置により種々変化させることに
より、陽圧状態では神経組織等の成長に必要な空間を確
保することができ、また陰圧状態では体液の滲出を促
し、損傷部表面の細胞増殖をより促進させることが可能
となる。さらに間欠的に陰圧に制御することで、閉鎖環
境内の体積の一時的な縮小により、均一かつ効率的な閉
鎖環境内の環流液の置換を行うことが可能となる。
The present invention according to claim 6 is a closed cell culture system in which the pressure in a closed environment is controlled continuously or intermittently. That is, by changing the pressure in the closed environment variously by, for example, a pressure maintaining device, it is possible to secure a space necessary for the growth of nerve tissue and the like in the positive pressure state, and to promote the exudation of body fluid in the negative pressure state. It is possible to further promote cell growth on the surface of the damaged part. Further, by intermittently controlling the negative pressure, it is possible to perform the uniform and efficient replacement of the reflux liquid in the closed environment by temporarily reducing the volume in the closed environment.

【0016】また、広範囲の重度火傷については、損傷
部に重大な体液水分損失が生じることがある。したがっ
て、本発明の閉鎖型細胞培養システムを用いて損傷部の
細胞培養を行う場合には、灌流液の浸透圧を火傷による
損傷部表面を適切に保つことが可能な浸透圧調整済みの
溶液を灌流液として循環させることが必要である。その
ための請求項7に記載の本発明は、外部に浸透圧調整済
みの灌流液を循環させるための回路を設けた閉鎖型細胞
培養システムである。
Further, with regard to a wide range of severe burns, a serious loss of water in body fluid may occur at the damaged portion. Therefore, when culturing cells in a damaged area using the closed cell culture system of the present invention, an osmotic pressure-adjusted solution capable of appropriately maintaining the osmotic pressure of the perfusate on the surface of the damaged area due to burns is used. It is necessary to circulate as a perfusate. Therefore, the present invention according to claim 7 is a closed cell culture system having a circuit for circulating the osmotic pressure-adjusted perfusate.

【0017】さらにまた、本発明の閉鎖型細胞培養シス
テムを用いて損傷部の細胞培養を行う場合において、損
傷部が、神経細胞断裂等の比較的深部の損傷であり、そ
のような神経細胞培養あるいは血管細胞培養の場合に
は、低侵襲でのアクセスが望ましい。かかるアクセスの
ためには、穿刺針の形態を採用するのがよい。したがっ
て、請求項8に記載の本発明は、穿刺デバイスとバルー
ンカテーテルの組合せにより、体腔内深部または臓器内
に細胞培養スペースを作る形態である閉鎖型細胞培養シ
ステムである。
Furthermore, when cell culture of a damaged part is performed using the closed cell culture system of the present invention, the damaged part is a relatively deep damage such as nerve cell tear, and such a nerve cell culture is performed. Alternatively, in the case of vascular cell culture, minimally invasive access is desirable. For such access, it is preferable to adopt the form of a puncture needle. Therefore, the present invention according to claim 8 is a closed cell culture system in which a cell culture space is formed deep inside a body cavity or in an organ by a combination of a puncture device and a balloon catheter.

【0018】すなわち、神経組織細胞や血管組織細胞の
増殖には、それが増殖するための空隙が確保されていな
ければならない。そのための空間を作成するのに穿刺針
とその内腔を通過するバルーン付カテーテルの組合せで
体内の目的部に到達させ、バルーンを拡張することによ
り目的細胞の増殖に適した空隙を作成させる。またそれ
により効果的に損傷部に生体吸収性材料を留置すること
ができる特徴を有するのである。
That is, for the growth of nerve tissue cells or vascular tissue cells, it is necessary to secure a space for the growth of the cells. In order to create a space therefor, a puncture needle and a catheter with a balloon passing through its lumen are used to reach a target part in the body, and the balloon is expanded to create a void suitable for the growth of target cells. Further, it has a feature that the bioabsorbable material can be effectively left in the damaged part.

【0019】また、肝臓、膵臓、腎臓などの実質臓器に
おいても同様の方法で培養スペースを設けて目的細胞を
各臓器内で培養することにより、機能の低下あるいは不
全状態の臓器内で、体外細胞培養技術による細胞培養以
上により優れた機能構造を有する細胞を増殖させること
ができる。
In addition, in the case of parenchymal organs such as liver, pancreas, kidney, etc., by culturing the target cells in each organ by providing a culture space in the same manner, in vitro organs can be obtained in organs with reduced function or in a defective state. Culturing cells by culturing technology Cells having an excellent functional structure can be grown by the above.

【0020】また、本発明は損傷部における細胞培養に
際し、効果的に有効な薬剤を投与し得る方法を提供する
ものである。すなわち、本発明が提供する閉鎖型細胞培
養システムにおいては、各細胞の増殖に最適な培地成分
への変換や、より治癒を促進させるために細胞増殖因子
や、血管増殖因子を灌流液に添加して欠損部を灌流させ
ることができる。したがって、請求項9に記載の本発明
は、請求項1に記載の閉鎖型細胞培養システムを利用し
て、灌流液中に治療薬剤を溶解させ、欠損部位の治療を
促進させる薬剤の投与方法でもある。治療薬剤の変更時
に薬剤が混合して不適切な薬剤の配合問題の発生を避け
るために、この場合にあっては、閉鎖環境に間欠的に陰
圧サイクルを施すことにより、閉鎖環境での細胞培養ス
ペース内を循環する灌流液を積極的に入れ替え、均一か
つ効率的な薬剤溶液の交換を行うことができる。
The present invention also provides a method capable of effectively administering an effective drug when culturing cells in a damaged area. That is, in the closed cell culture system provided by the present invention, a cell growth factor or a vascular growth factor is added to the perfusate in order to promote conversion to a medium component optimal for the growth of each cell or to promote healing. The defect can be perfused. Therefore, the present invention according to claim 9 is also a method for administering a drug, which utilizes the closed cell culture system according to claim 1 to dissolve a therapeutic agent in perfusate and accelerate treatment of a defect site. is there. In order to avoid the occurrence of improper drug compounding problems caused by the mixing of drugs when changing the therapeutic drug, in this case, cells in a closed environment are subjected to intermittent negative pressure cycles. The perfusate circulating in the culture space can be positively replaced to uniformly and efficiently exchange the drug solution.

【0021】かかる場合に投与し得る薬剤としては、消
毒剤、局所麻酔剤、消炎鎮痛剤、抗生物質製剤、末梢血
管拡張剤、各種細胞増殖因子製剤、神経増殖因子製剤、
血管増殖因子製剤(癌細胞摘出時には、各種細胞増殖抑
制因子製剤)、免疫抑制剤等を挙げることができる。
Drugs that can be administered in such cases include antiseptics, local anesthetics, anti-inflammatory analgesics, antibiotics, peripheral vasodilators, various cell growth factor preparations, nerve growth factor preparations,
Examples include vascular growth factor preparations (various cell growth inhibitor preparations at the time of removing cancer cells), immunosuppressants, and the like.

【0022】またこれらの薬剤のみならず、各種細胞接
着性分子、例えば、フィブロネクチン、ヒドロネクチン
等を灌流液中に含有させてもよい。また遺伝子を導入さ
せることもでき、そのような遺伝子としては、ネイキッ
ドDNA、アデノウイルスベクター遺伝子、レトロウイ
ルスベクター遺伝子、リポゾーム埋抱遺伝子、ハイドロ
ゲル埋抱遺伝子等を挙げることができる。
In addition to these drugs, various cell adhesive molecules such as fibronectin and hydronectin may be contained in the perfusate. A gene can also be introduced, and examples of such a gene include naked DNA, adenovirus vector gene, retrovirus vector gene, liposome embedding gene, hydrogel embedding gene and the like.

【0023】さらに本発明の別の態様としての請求項1
0に記載の発明は、予め自己の細胞を採取し、体外でそ
の細胞を培養増殖させた後に灌流液に懸濁し、灌流シス
テムを通じて閉鎖型培養システムに戻すことにより、損
傷部細胞培養からの治療を行うと同時に、体外で培養し
た組織と複合的に培養増殖、生着を行うことにより損傷
部の治癒を促進させる細胞の移送と増殖方法でもある。
Claim 1 as another aspect of the present invention
The invention described in 0 is a treatment from injured cell culture by collecting autologous cells in advance, culturing and proliferating the cells in vitro, suspending the cells in a perfusate, and returning the cells to a closed culture system through the perfusion system. Simultaneously with the above, it is also a method of transferring and proliferating cells which promotes healing of a damaged part by carrying out culture proliferation and engraftment in combination with tissues cultured in vitro.

【0024】[0024]

【発明の実施の形態】以下に、本発明が提供する閉鎖型
細胞培養システムについて、図面を参照にしながら詳細
に説明をして行く。
BEST MODE FOR CARRYING OUT THE INVENTION The closed cell culture system provided by the present invention will be described below in detail with reference to the drawings.

【0025】図1は、本発明が提供する閉鎖型細胞培養
システムを説明するための概略分解模式図である。すな
わち、本発明が提供する閉鎖型細胞培養システム(1)
は、基本的には、体表面もしくは体内の組織欠損部
(2)を外部から密閉することにより細菌等の侵入を防
御した閉鎖環境となし、当該閉鎖した組織欠損部へ細胞
培養に適した溶液を循環させることにより欠損部組織の
再生を行うことを特徴とする閉鎖型細胞培養システムで
ある。
FIG. 1 is a schematic exploded schematic view for explaining the closed cell culture system provided by the present invention. That is, the closed cell culture system (1) provided by the present invention
Is basically a solution suitable for cell culture to the closed tissue defect portion by providing a closed environment in which the invasion of bacteria and the like is protected by sealing the tissue defect portion (2) inside the body or the body from the outside. The closed cell culture system is characterized in that the defective tissue is regenerated by circulating.

【0026】より具体的には、本発明が提供する閉鎖型
細胞培養システム(1)(図中においては閉鎖状態を解
除した、模式的展開図で示してある)は、体表面もしく
は体内の組織欠損部(2)を外部から密閉する手段
(3)(図中においてはサージカルフィルム等の粘着シ
ート)により細菌等の侵入を防御した閉鎖環境、すなわ
ち、体表面の組織欠損部(2)をサージカルフィルム
(3)により被覆密閉することにより閉鎖環境を作り出
し、その閉鎖した組織欠損部(2)へ細胞培養に適した
溶液を灌流液導入チューブ(10)(図中、矢印A方
向)より導入して、灌流液排出チューブ(11)(図
中、矢印B方向)へ灌流させる。
More specifically, the closed cell culture system (1) provided by the present invention (in the figure, the closed state is released and shown in a schematic development view) is a body surface or a tissue in the body. A closed environment in which the invasion of bacteria and the like is prevented by means (3) (an adhesive sheet such as a surgical film in the figure) for sealing the defect (2) from the outside, that is, the tissue defect (2) on the body surface is surgically A closed environment is created by covering and sealing with a film (3), and a solution suitable for cell culture is introduced into the closed tissue defect part (2) from a perfusion solution introduction tube (10) (direction of arrow A in the figure). To perfuse the perfusate discharge tube (11) (in the direction of arrow B in the figure).

【0027】灌流液導入チューブ(10)よりシステム
(1)内に灌流された灌流液は、ディスク2(5)を介
して例えば表皮用生体吸収性材料(6)へ浸漬し、浸漬
された灌流液がその下方で体組織欠損部(2)へ埋没さ
せた埋没生体吸収性材料(7)にさらに浸漬し、その場
で体組織欠損部(2)における細胞に細胞増殖に適した
環境を与えることとなり、細胞増殖を効率的に行うこと
となる。
The perfusion solution perfused into the system (1) from the perfusion solution introduction tube (10) is immersed in, for example, the bioabsorbable material for epidermis (6) through the disc 2 (5), and the perfusion solution is immersed. The liquid is further immersed in the buried bioabsorbable material (7) which is buried in the body tissue defect portion (2) thereunder, and the cells in the body tissue defect portion (2) are provided with an environment suitable for cell growth on the spot. This results in efficient cell growth.

【0028】一方、埋没生体吸収性材料(7)を浸漬
し、さらに体組織欠損部(2)を満たした灌流液は、デ
ィスク1(4)およびディスク2(5)の間の空域を通
って、ディスク1(4)に設けられた灌流液排出チュー
ブ(11)より排出され、灌流が完了する。
On the other hand, the perfusate in which the buried bioabsorbable material (7) was dipped and the body tissue defect portion (2) was filled, passed through the air space between the disks 1 (4) and 2 (5). , Is discharged from the perfusion liquid discharge tube (11) provided on the disk 1 (4), and the perfusion is completed.

【0029】なお、システム内に設けたディスク1
(4)とディスク2(5)の2層ディスクは、それぞれ
灌流液導入チューブ(10)および灌流液排出チューブ
(11)を保持する機構を有すればよく、またその材料
も非透水性のプラスチック等でチューブと一体で成形す
ることができる。
Incidentally, the disk 1 provided in the system
The two-layer disc of (4) and disc 2 (5) may have a mechanism for holding the perfusate introduction tube (10) and the perfusate discharge tube (11), respectively, and the material thereof is a non-permeable plastic. It can be molded integrally with the tube.

【0030】以上に説明したように、本発明のシステム
(1)による体組織欠損部での閉鎖環境内への灌流液の
循環により、体組織欠損部には、細胞が接着する足場と
なる生体吸収性材料により、効率的に細胞増殖をが促進
させ、細胞増殖が完了した段階では、足場となる生体吸
収性材料が分解吸収されており、滅菌状態で体欠損部の
組織の再生が行われるのである。
As described above, the system (1) according to the present invention circulates the perfusate into the closed environment at the body tissue defect portion, whereby the living body becomes a scaffold to which cells adhere to the body tissue defect portion. Cellular growth is efficiently promoted by the absorbable material, and when the cell growth is completed, the bioabsorbable material that serves as a scaffold is decomposed and absorbed, and the tissue of the body defect site is regenerated in a sterile state. Of.

【0031】図2に体表面から本発明の閉鎖型組織培養
システム(20)をアクセスした概略断面を示した。す
なわち、外傷、火傷、褥瘡などの傷害の場合には、表皮
(21)および真皮(22)を含め体組織が欠損し、そ
の傷害部が体表面に露出している。この場合には、被覆
フィルム(23)がついた本発明の閉鎖型組織培養シス
テム(20)の2層ディスク創面アダプター(24)を
傷害面に充て、灌流液を灌流させる。なお、この場合に
おいても、細胞増殖の必要な組織には、細胞増殖を促進
させる適当な足場生体材料(25)として、生体吸収性
材料を埋植させて細胞増殖部(26)を作成させておく
のがよい。
FIG. 2 shows a schematic cross section obtained by accessing the closed tissue culture system (20) of the present invention from the body surface. That is, in the case of injury such as trauma, burns, pressure ulcers, body tissues including the epidermis (21) and the dermis (22) are lost, and the injured part is exposed on the body surface. In this case, the wound surface is filled with the two-layer disc wound surface adapter (24) of the closed-type tissue culture system (20) of the present invention having the coating film (23), and the perfusate is perfused. Even in this case, a bioresorbable material is embedded as a suitable scaffold biomaterial (25) for promoting cell growth in a tissue requiring cell growth to form a cell growth part (26). It's good to leave.

【0032】この場合にあっては、灌流液は閉鎖型組織
培養システム(20)の中央部に設けた灌流液入口(2
8)より灌流されて損傷部に流れ、生体吸収性材料であ
る足場生体材料(25)につたわり、周辺部に拡散す
る。その後、周辺部単端(27)より2層ディスク(2
4)の間隙を通り、灌流液出口(29)より排液として
排出される。
In this case, the perfusate is the perfusate inlet (2) provided at the center of the closed tissue culture system (20).
8) It is perfused from 8), flows to the damaged part, is attached to the scaffold biomaterial (25) which is a bioabsorbable material, and diffuses to the peripheral part. After that, from the single edge (27) of the peripheral portion to the two-layer disc (2
It passes through the gap of 4) and is discharged as drainage from the perfusate outlet (29).

【0033】したがって、傷害面が密閉状態であること
より細菌等からの感染が防止でき、灌流液ならびに足場
生体材料により、損傷部での細胞増殖が効果的に行われ
ることとなる。
Therefore, since the injured surface is in a sealed state, infection from bacteria or the like can be prevented, and the perfusate and the scaffolding biomaterial can effectively proliferate cells at the damaged part.

【0034】この体表面へアクセスする本発明の閉鎖型
組織培養システムは、個々の傷害部の大きさにあわせ、
所望のサイズに設計することができる。したがって、広
範囲の火傷などの場合にあっては、2層ディスクを有す
る本発明の閉鎖型組織培養システムを複数組合せること
により火傷の面積と形状に合わせ、同時に各システムへ
灌流液を灌流させ、単独使用の場合と同様の効果を上げ
ることができる。
The closed-type tissue culture system of the present invention for accessing the body surface is adapted to the size of each injured part,
It can be designed to any desired size. Therefore, in the case of a wide range of burns and the like, the closed tissue culture system of the present invention having a two-layer disc is combined to match the area and shape of the burn, and at the same time, the perfusate is perfused into each system. The same effect as when used alone can be obtained.

【0035】一方、神経細胞断裂あるいは血管組織の断
裂等、体内の比較的深部の損傷部における細胞増殖を行
う場合には、低侵襲でのアクセスが望ましいことより、
穿刺針の形態の閉鎖型細胞培養システムが使用される。
具体的には、神経組織細胞や血管組織細胞増殖のための
空隙を穿刺針とその内腔を通過するバルーン付カテーテ
ルの組合せで作成し、そのバルーンで拡張させた部位に
足場生体材料を留置させ、灌流用カテーテルにより灌流
液を循環することができる。なお、この場合に使用する
穿刺針は、柔軟に屈曲することができ、細胞増殖を目的
とする損傷部に添ったカテーテルの留置が行えるよう構
成されている。
On the other hand, in the case of performing cell proliferation in a relatively deeply damaged area in the body such as nerve cell tear or vascular tissue tear, it is desirable to access with minimally invasiveness.
A closed cell culture system in the form of a needle is used.
Specifically, create a space for proliferation of nerve tissue cells and vascular tissue cells with a combination of a puncture needle and a catheter with a balloon that passes through the lumen, and place the scaffold biomaterial at the site expanded with the balloon. The perfusion fluid can be circulated by the perfusion catheter. The puncture needle used in this case can be flexibly bent, and the catheter can be placed along the damaged portion for the purpose of cell proliferation.

【0036】かかる体内の比較的深部の損傷部、例え
ば、神経細胞断裂あるいは血管組織の断裂等における細
胞増殖のための本発明のシステムによる細胞増殖の概念
を図3〜図6により示した。すなわち図3に示すような
穿刺針(30)を用い、皮膚表面より穿刺針を刺し、細
胞増殖のための空隙を構築する目的部まで先端を導入さ
せ、穿刺針の先端孔よりバルーンカテーテルを、穿刺針
先端を後退させながらカテーテルバルーン部(31)を
露出させてバルーン部(32)を膨張させる。
The concept of cell proliferation by the system of the present invention for cell proliferation in a relatively deeply damaged part in the body, for example, nerve cell disruption or vascular tissue disruption is shown in FIGS. That is, using a puncture needle (30) as shown in FIG. 3, the puncture needle is pierced from the skin surface to introduce a tip to a target portion for forming a void for cell proliferation, and a balloon catheter is introduced from the tip hole of the puncture needle. While retracting the tip of the puncture needle, the catheter balloon part (31) is exposed and the balloon part (32) is inflated.

【0037】次いで、バルーンの膨張により細胞増殖の
ための空隙部(組織内スペース)を作成した後、図4に
示すように、バルーンを縮小させてバルーンカテーテル
のみを抜去する。その後細胞増殖の足場となる生体吸収
性材料(33)を穿刺針(30)内腔から挿入する。な
お生体吸収性材料は、予めルーメン内に含んでいるカテ
ーテルを、穿刺針を通じて留置することもできる。
Then, after expanding the balloon to create a void (intra-tissue space) for cell proliferation, the balloon is contracted and only the balloon catheter is removed, as shown in FIG. After that, a bioabsorbable material (33) serving as a scaffold for cell proliferation is inserted from the lumen of the puncture needle (30). The bioabsorbable material may be left indwelling through a puncture needle, which is a catheter that is contained in the lumen in advance.

【0038】細胞増殖の足場となる生体吸収性材料を損
傷部に留置し、生体吸収性材料埋入用カテーテルを抜去
した後、図5に示すように細胞増殖に適する灌流液を灌
流させるための、灌流用2重ルーメンカテーテル(3
4)を挿入し、次いで灌流用カテーテル(34)のみを
残し、穿刺針を体内より引き抜き、灌流液の入口(3
5)と出口(36)を灌流システムに接続し、灌流を開
始する。かかる状態を、図6に模式的に示した。
[0038] A bioabsorbable material that serves as a scaffold for cell proliferation is left in the injured part, the catheter for embedding the bioabsorbable material is removed, and then a perfusion solution suitable for cell proliferation is perfused as shown in FIG. , Double lumen catheter for perfusion (3
4) is inserted, then only the perfusion catheter (34) is left, the puncture needle is pulled out from the body, and the perfusion fluid inlet (3
5) Connect the outlet (36) to the perfusion system and start the perfusion. This state is schematically shown in FIG.

【0039】以上記載のように、本発明の閉鎖型細胞培
養システムを使用することにより、体表面もしくは体内
の組織欠損部を外部から密閉し、細菌等の侵入を防御し
た閉鎖環境とすることができ、当該閉鎖した組織欠損部
へ細胞培養に適した溶液を循環させることで欠損部の細
胞増殖を行い、組織の再生を行うことが可能となる。
As described above, by using the closed cell culture system of the present invention, the body surface or the tissue defect part in the body can be sealed from the outside to form a closed environment in which invasion of bacteria and the like is prevented. It is possible to circulate a solution suitable for cell culture to the closed tissue defect portion to grow cells in the defect portion and regenerate tissue.

【0040】また本発明が提供する閉鎖型細胞培養シス
テムは、循環させる溶液成分を段階ごとの変化させるこ
とにより、欠損部の鎮痛、消毒、各再生目的組織にとっ
て適した細胞増殖環境を構築させることもできるもので
ある。例えばそのような手段として、模式的な概念図と
して図7に示すように、細胞培養灌流液の入った複数の
容器(40)(図にあっては2個)からその灌流液の種
類を切り換えることができる3方活栓(41)を通り、
流量調節器(42)により流量を制御した後、患者(4
6)に設けた閉鎖型細胞培養システム(閉鎖型培養器)
(43)内を灌流した後、ポンプ(44)を通って排液
容器に灌流後の培養液を廃棄(45)することができ
る。
In the closed cell culture system provided by the present invention, the solution components to be circulated are changed step by step to provide analgesia of the defective portion, disinfection, and the construction of a cell growth environment suitable for each regeneration target tissue. It is also possible. For example, as such means, as shown in FIG. 7 as a schematic conceptual diagram, the type of the perfusate is switched from a plurality of containers (40) (two in the figure) containing the cell culture perfusate. Through a 3-way stopcock (41)
After controlling the flow rate by the flow rate controller (42), the patient (4
6) Closed cell culture system (closed incubator)
After perfusing the inside of (43), the culture solution after perfusion can be discarded (45) through the pump (44) into the drainage container.

【0041】この場合には、例えば圧力センサーなどを
用いてポンプの排出量を制御することができ、それによ
り細胞増殖を行う目的損傷部の圧力を一定に保つことも
できる。
In this case, the discharge amount of the pump can be controlled by using, for example, a pressure sensor or the like, and thereby the pressure of the target damaged portion for cell proliferation can be kept constant.

【0042】この複数の灌流液を使用する場合において
は、単に細胞増殖に適した複数の成分を灌流させるばか
りでなく、汚染されている創傷部を消毒する殺菌剤、あ
るいは細菌類の増殖を抑制させるための抗生物質を初期
の段階で灌流させること、さらには、よりよい治癒の促
進を目的として各種細胞増殖因子、神経増殖因子、血管
増殖因子(癌細胞摘出時には、各種細胞増殖抑制因子)
等を含有する灌流液を灌流させることができる。
In the case of using the plurality of perfusates, not only perfusing a plurality of components suitable for cell growth but also a bactericidal agent for disinfecting a contaminated wound site or the growth of bacteria is suppressed. Perfusion of antibiotics to induce perfusion at an early stage, and further various cell growth factors, nerve growth factors, and blood vessel growth factors (various cell growth suppression factors at the time of cancer cell removal) for the purpose of promoting better healing
Can be perfused with a perfusate containing

【0043】またさらに効果的な治療のために局所麻酔
剤、消炎鎮痛剤、抗生物質製剤、末梢血管拡張剤、免疫
抑制剤等を含有する灌流液を灌流させることができる。
For more effective treatment, a perfusion solution containing a local anesthetic, an anti-inflammatory analgesic, an antibiotic agent, a peripheral vasodilator, an immunosuppressant, etc. can be perfused.

【0044】また、細胞の培養環境は、細胞の培養に伴
ってその培養環境内部のpH値、炭酸ガス分圧、酸素分
圧が種々変化する。したがって、培養環境である閉鎖環
境は、常に細胞培養に最適な環境にしておくことが好ま
しい。そのためには、センサーにより閉鎖環境の培養液
内の物理的要因、すなわちpH値、炭酸ガス分圧、酸素
分圧を測定、モニターするモニター(47)を設け、モ
ニターからの信号により培養環境の入口側に設けたガス
交換器(48)を制御し、リアルタイムで培養液の変化
に合せて閉鎖環境のガス分圧の調整をおこない、細胞培
養環境を最適化しておくことができる。
Further, in the cell culture environment, the pH value, the carbon dioxide gas partial pressure, and the oxygen partial pressure inside the culture environment change variously as the cells are cultured. Therefore, it is preferable that the closed environment, which is the culture environment, is always the optimum environment for cell culture. For that purpose, a sensor (47) for measuring and monitoring physical factors in the culture medium in a closed environment, that is, pH value, carbon dioxide partial pressure, and oxygen partial pressure is provided by a sensor, and a signal from the monitor is used to enter the inlet of the culture environment. It is possible to optimize the cell culture environment by controlling the gas exchanger (48) provided on the side and adjusting the gas partial pressure of the closed environment in real time according to the change of the culture solution.

【0045】本発明が提供する閉鎖型細胞培養システム
は、また病院等で常用されている定圧持続吸引器と輸液
バックと輸液チューブ回路を利用して細胞培養に適した
灌流液を灌流させることもできる。その模式的な概念を
図8として示した。なお、図8において、図中の符号
は、図7と同一意味を有する。
The closed cell culture system provided by the present invention can also perfuse a perfusate suitable for cell culture using a constant pressure continuous aspirator, an infusion bag and an infusion tube circuit that are commonly used in hospitals and the like. it can. The schematic concept is shown in FIG. Note that, in FIG. 8, reference numerals in the drawing have the same meanings as in FIG. 7.

【0046】図8においても、その基本的概念は、図7
に示したシステムと同様であり、図7で設けたポンプを
通って排液容器に灌流後の培養液を廃棄する部分を、病
院等で常用されている定圧持続吸引器(51)に接続し
た部分が異なるだけである。
Also in FIG. 8, the basic concept is as shown in FIG.
Similar to the system shown in FIG. 7, the part for discarding the culture solution after perfusion into the drainage container through the pump provided in FIG. 7 was connected to a constant pressure continuous aspirator (51) commonly used in hospitals and the like. Only the parts are different.

【0047】以上記載のように、本発明は欠損損傷部の
傷口において、壊死組織等の不要物を除去した後、細胞
増殖の足場となる生体吸収性材料を欠損スペースに埋植
させ、欠損部を外部から閉鎖させると共に、その閉鎖部
分へ細胞培養に適した溶液を循環させることにより、そ
の場で効率的に欠損部細胞を増殖させ、組織の再生を行
うことができる。
As described above, according to the present invention, after removing unnecessary substances such as necrotic tissue at the wound of the defect damaged portion, a bioabsorbable material that serves as a scaffold for cell proliferation is embedded in the defect space, The cells can be closed from the outside and a solution suitable for cell culture is circulated to the closed portion, so that defective cells can be efficiently proliferated in situ to regenerate the tissue.

【0048】[0048]

【実施例】以下に本発明の細胞増殖の具体例を、実施例
により説明する。 実施例1:移植皮膚採取手術後の損傷部の治療 採皮手術後の創面からの出血を、フィブリンスプレーを
用いて速やかに止血させ、周辺部を消毒した。次いで、
凹んだ部分にコラーゲンビーズを充填した後に中心部に
穴のあいた連続気泡コラーゲンシートを創面にそって大
きめに形を作り創面に被せた。2層アダプターもコラー
ゲンシートと同様の形にした後に上に重ねて、アダプタ
ーの出入り口のみ開孔したサージカルフィルムを被せて
コラーゲンビーズとシートの閉鎖スペースを作成した。
採皮個所に痛みのある場合は、局所麻酔剤としてキシロ
カイン、さらに3種混合の抗生物質の入った血漿製剤を
閉鎖スペースに循環させ、3時間後に局所麻酔剤と抗生
物質溶液を止めて,塩基性繊維芽細胞増殖因子(bFG
F)に切り換えて灌流した。
EXAMPLES Specific examples of cell proliferation of the present invention will be described below with reference to Examples. Example 1 Treatment of Damaged Site after Surgery for Grafted Skin The hemorrhage from the wound surface after skin removal surgery was immediately stopped by using fibrin spray, and the peripheral area was disinfected. Then
After filling the recessed portion with collagen beads, an open-cell collagen sheet having a hole in the center was formed into a larger shape along the wound surface, and the wound surface was covered. The two-layer adapter was also formed into a shape similar to that of the collagen sheet and then laminated on it, and a surgical film having openings only at the entrance and exit of the adapter was covered to form a closed space between the collagen beads and the sheet.
If there is pain in the skin-cutting area, a plasma preparation containing xylocaine as a local anesthetic and a mixed antibiotic of three kinds is circulated in the closed space, and after 3 hours, the local anesthetic and the antibiotic solution are stopped, and a base is added. Fibroblast growth factor (bFG
Perfusion was performed by switching to F).

【0049】別途に真皮層の組織を採取し、体外でウシ
胎児血清により細かく浮遊培養した繊維芽細胞を患者の
血清と交換し灌流した。その細胞混濁溶液を潅流液バッ
クの下の3方活栓より閉鎖型培養器に注入する事により
細胞移植を行った。続いて真皮細胞の細胞増殖が終了し
た時点でbFGFを上皮増殖因子(EGF)に交換して
周囲の皮膚表面と均一になるまで上皮細胞を培養した。
Separately, the tissue of the dermal layer was collected, and the fibroblasts finely suspension-cultured in vitro with fetal bovine serum were replaced with the serum of the patient and perfused. Cell transplantation was carried out by injecting the cell turbid solution into a closed type incubator through a three-way stopcock under a perfusate bag. Then, when the cell proliferation of dermal cells was completed, bFGF was exchanged for epidermal growth factor (EGF) and the epithelial cells were cultured until they became uniform with the surrounding skin surface.

【0050】実施例2:下肢大腿部断裂神経の神経再構
築 体表面の皮膚から柔軟に曲げることのできる穿刺針を、
神経の断裂個所両端の神経に届くように穿刺する。バル
ーン長が神経両断端に届く長さのものを選び、バルーン
カテーテルを、穿刺針を通じて挿入してバルーンを膨張
させ、神経の断端間に空隙を作る。
Example 2 A puncture needle which can be flexibly bent from the skin on the surface of the nerve reconstructed nerve of the femoral rupture nerve of the lower limbs,
Puncture the nerve so that it reaches the nerves at both ends. A balloon having a length that can reach both nerve stumps is selected, and a balloon catheter is inserted through a puncture needle to inflate the balloon to create a space between nerve stumps.

【0051】その空隙に神経成長の足場となる平行コラ
ーゲン繊維束をルーメン内に収納したカテーテルより挿
入する。さらにこのカテーテルを潅流用細径カテーテル
と交換し穿刺針を抜き取り潅流用カテーテルのみを留置
する。
A parallel collagen fiber bundle, which serves as a scaffold for nerve growth, is inserted into the void with a catheter housed in the lumen. Further, this catheter is replaced with a thin catheter for perfusion, the puncture needle is removed, and only the catheter for perfusion is left indwelling.

【0052】患者の血液より得た血清に神経増殖因子を
10−8モル加え、灌流を開始し、内部の空気が出終わ
った時点で循環回路に切り換える。
Nerve growth factor ( 10-8 mol) is added to the serum obtained from the patient's blood, perfusion is started, and the circulation circuit is switched to when the internal air is released.

【0053】灌流時に神経断端間のスペースがつぶれな
いように、弱い陽圧を維持する。細胞が充分に成長した
時点で潅流用カテーテルを抜き取り、完了する。
A slight positive pressure is maintained so that the space between nerve stumps does not collapse during perfusion. When the cells have grown sufficiently, the perfusion catheter is removed and completed.

【0054】実施例3:重度の火傷の治療 腹部に対する重度の火傷に対して皮膚と死滅組織等を切
除した後に、コラーゲン繊維シートで火傷創面を覆い、
さらにその上に2層灌流アダプターを取りつける。最初
にポピドンヨード液を含む等張血漿増量製剤により創面
を消毒する。
Example 3 Treatment of Severe Burn Injury After the skin and dead tissue were excised for severe burn of the abdomen, the burn wound surface was covered with a collagen fiber sheet,
Further, a two-layer perfusion adapter is attached on it. The wound surface is first disinfected with an isotonic plasma bulking formulation containing povidone iodine solution.

【0055】浸透圧を火傷創面と同等にしたヒト血漿製
剤を患者の創面からの体液損失を抑制する為に灌流させ
る。また感染を予防する為に抗生物質注射液を加えて、
さらに患者が痛みを訴える様であれば、局所麻酔剤であ
るキシロカインを灌流液に注入して鎮痛をおこなう。
A human plasma preparation having an osmotic pressure equal to that of the wound surface is perfused in order to suppress the loss of body fluid from the wound surface of the patient. In addition, add antibiotic injections to prevent infection,
In addition, if the patient complains of pain, xylocaine, a local anesthetic, is injected into the perfusate to provide analgesia.

【0056】患者の状態が安定した後にキシロカイン、
抗生物質の投与を中止して繊維芽細胞増殖因子(bFG
F)、血小板由来細胞増殖因子(PDGF)、表皮増殖
因子等の細胞増殖因子を灌流液に加える。創面の表皮が
充分に増殖した時点でこの閉鎖型細胞培養器を取り外
し、創面を外気に触れさせながら、残りの自然治癒を待
つ。
Xylocaine after the patient's condition has stabilized,
Administration of antibiotics was discontinued and fibroblast growth factor (bFG
F), cell growth factors such as platelet-derived cell growth factor (PDGF) and epidermal growth factor are added to the perfusate. When the epidermis on the wound surface has sufficiently grown, the closed cell culture device is removed, and the wound surface is exposed to the outside air, and the rest of the natural healing is awaited.

【0057】実施例4:ウサギ肝臓に穿刺針付きのカテ
ーテルイントロデューサーを、超音波断層画像を見なが
ら穿刺する。イントロデューサーシースを残して穿刺針
を抜去し、代わりにフォガティー血栓除去用バルーンカ
テーテルを挿入し、径が2cm程度となるまでバルーン
を膨張させて肝臓内に細胞培養スペースを確保した。バ
ルーンを縮小させた後、そのフォガティーカテーテルを
抜き取り、綿状のコラーゲン繊維ペレットの入ったテフ
ロン(登録商標)チューブを培養スペースに挿入し、コ
ラーゲン繊維ペレットを充填した。コラーゲン挿入用の
テフロン(登録商標)チューブを抜き去り、灌流用の2
重ルーメンの灌流口が培養スペースに位置するように留
置し、カテーテルイントロデューサーシースも抜去して
2重ルーメンカテーテルのみを残し、縫合により皮膚に
固定し、同時にカテーテル創外固定用のフィルムで固定
した。
Example 4: A rabbit liver is punctured with a catheter introducer equipped with a puncture needle while observing an ultrasonic tomographic image. The puncture needle was removed while leaving the introducer sheath, and a balloon catheter for removing a Fogerty thrombus was inserted instead, and the balloon was inflated until the diameter became about 2 cm to secure a cell culture space in the liver. After shrinking the balloon, the Fogerty catheter was removed, and a Teflon (registered trademark) tube containing a cotton-like collagen fiber pellet was inserted into the culture space to fill the collagen fiber pellet. Remove the Teflon (registered trademark) tube for inserting collagen and use 2 for perfusion.
The catheter was placed so that the perfusion port of the heavy lumen was located in the culture space, the catheter introducer sheath was also removed, leaving only the double lumen catheter, and fixed to the skin by suturing, and at the same time fixed with a film for external fixation of the catheter. .

【0058】当該ウサギの血液より調製した血清を細胞
培養スペースに灌流させつつ、30日間ウサギ肝臓内で
肝細胞の培養を行った。
While the serum prepared from the blood of the rabbit was perfused into the cell culture space, hepatocytes were cultured in the rabbit liver for 30 days.

【0059】30日の処理後、ウサギを屠殺し、処理肝
臓の剖検の結果、コラーゲン繊維内に肝臓細胞の増殖培
養が認められた。
After the treatment for 30 days, the rabbits were sacrificed, and the autopsy of the treated liver revealed that hepatocytes were proliferated and cultured in the collagen fibers.

【0060】[0060]

【発明の効果】以上記載のように、本発明の閉鎖型細胞
培養システムにより、欠損部を外部から閉鎖させること
により細菌からの感染を防御し、その閉鎖部分へ細胞培
養に適した溶液を循環させることにより、その場で効率
的に欠損部細胞を増殖させ、組織の再生を行うことがで
きる利点を有している。
As described above, according to the closed cell culture system of the present invention, the defective portion is closed from the outside to prevent infection from bacteria, and a solution suitable for cell culture is circulated to the closed portion. This has the advantage that the defective cells can be efficiently proliferated on the spot to regenerate the tissue.

【0061】また、灌流液を種々変化させることによ
り、細胞増殖因子、あるいは治療用薬剤を効果的に目的
の部に投与することができ、より効果的な組織再生を確
保し得る利点を有している。
Further, by changing the perfusate variously, the cell growth factor or the therapeutic drug can be effectively administered to the target site, and there is an advantage that more effective tissue regeneration can be secured. ing.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の閉鎖型細胞培養システムを説明するた
めの模式的概略分解図である。
FIG. 1 is a schematic schematic exploded view for explaining a closed cell culture system of the present invention.

【図2】体表面に本発明の閉鎖型細胞培養システムをア
クセスした概略断面図である。
FIG. 2 is a schematic cross-sectional view in which the closed cell culture system of the present invention is accessed on the body surface.

【図3】体内の深部の損傷部である神経細胞断裂におけ
る細胞増殖のための本発明のシステムによる細胞増殖の
概念を説明する図である。
FIG. 3 is a diagram explaining the concept of cell proliferation by the system of the present invention for cell proliferation in nerve cell tear, which is a deeply damaged area in the body.

【図4】体内の深部の損傷部である神経細胞断裂におけ
る細胞増殖のための本発明のシステムによる細胞増殖の
概念を説明する図である。
FIG. 4 is a diagram illustrating the concept of cell proliferation by the system of the present invention for cell proliferation in nerve cell tear, which is a deeply damaged area in the body.

【図5】体内の深部の損傷部である神経細胞断裂におけ
る細胞増殖のため、本発明のシステムによる細胞増殖の
概念の説明図である。
FIG. 5 is an explanatory view of the concept of cell proliferation by the system of the present invention due to cell proliferation in nerve cell tear, which is a deeply damaged part in the body.

【図6】体内の深部の損傷部である神経細胞断裂におけ
る細胞増殖のため、本発明のシステムによる細胞増殖の
概念の説明図である。
FIG. 6 is an explanatory view of the concept of cell proliferation by the system of the present invention due to cell proliferation in nerve cell tear, which is a deeply damaged area in the body.

【図7】本発明の閉鎖型細胞培養システムにより、複数
の灌流液を循環させる場合の模式的な説明図である。
FIG. 7 is a schematic explanatory diagram of a case where a plurality of perfusates are circulated by the closed cell culture system of the present invention.

【図8】本発明の閉鎖型細胞培養システムを、定圧持続
吸引器と輸液バックと輸液チューブ回路を利用して灌流
液を灌流させる場合の模式的な説明図である。
FIG. 8 is a schematic explanatory view of the closed cell culture system of the present invention in which a perfusate is perfused using a constant pressure continuous inhaler, an infusion bag, and an infusion tube circuit.

【符号の説明】[Explanation of symbols]

1 閉鎖型細胞培養システム 2 体組織欠損部 3 サージカルフィルム 7 埋没生体吸収性材料 20 閉鎖型細胞培養システム 23 被覆フィルム 24 2層ディスク 25 足場生体材料 26 細胞増殖部 30 穿刺針 32 バルーン部 33 生体吸収性材料 34 2重ルーメンカテーテル 40 灌流液バッグ 41 3方活栓 42 流量調節 43 閉鎖型型細胞培養器基 44 ポンプ 45 廃棄 46 患者 47 pH ガスモニター 48 ガス交換器 51 定圧持続吸引器 1 Closed cell culture system 2 Body tissue defect 3 Surgical film 7 Buried bioabsorbable material 20 Closed cell culture system 23 Covering film 24 dual layer disc 25 Scaffolding biomaterial 26 Cell Proliferation Department 30 puncture needle 32 balloon 33 Bioabsorbable material 34 double lumen catheter 40 perfusate bag 41 3-way stopcock 42 Flow rate adjustment 43 Closed Cell Culture Substrate 44 pumps 45 disposal 46 patients 47 pH gas monitor 48 gas exchanger 51 Constant Pressure Continuous Aspirator

フロントページの続き Fターム(参考) 4B065 AA90X AA93X BA30 BB01 BB25 BB40 BC02 BC06 BC07 BC14 BC15 BC50 CA43 CA44 4C081 AC08 BA12 CE02 4C087 BB34 BB35 BB38 MA17 MA66 NA05 NA10 ZA01 ZA89 Continued front page    F-term (reference) 4B065 AA90X AA93X BA30 BB01                       BB25 BB40 BC02 BC06 BC07                       BC14 BC15 BC50 CA43 CA44                 4C081 AC08 BA12 CE02                 4C087 BB34 BB35 BB38 MA17 MA66                       NA05 NA10 ZA01 ZA89

Claims (10)

【特許請求の範囲】[Claims] 【請求項1】 体表面もしくは体内の組織欠損部を外部
から密閉することにより細菌等の侵入を防御した閉鎖環
境となし、当該閉鎖した組織欠損部へ細胞培養に適した
溶液を循環させることにより欠損部組織の再生を行うこ
とを特徴とする閉鎖型細胞培養システム。
1. A closed environment in which the invasion of bacteria and the like is protected by sealing a tissue defect portion on the body surface or in the body from the outside, and a solution suitable for cell culture is circulated to the closed tissue defect portion. A closed cell culture system characterized by performing regeneration of defective tissue.
【請求項2】 閉鎖環境内に生体吸収性材料を埋植し
て、欠損部組織細胞の再生を促進させる請求項1に記載
の閉鎖型細胞培養システム。
2. The closed cell culture system according to claim 1, wherein a bioabsorbable material is embedded in a closed environment to promote regeneration of defective tissue cells.
【請求項3】 細胞培養に適した溶液が、自己血から分
離した血清、、血漿血液製製剤、血小板濃厚血清、血漿
分画製剤、血液蛋白分画成分溶液、プラズマエキスパン
ダー、浸透圧等張輸液、細胞培養培地である請求項1ま
たは2に記載の閉鎖型細胞培養システム。
3. A solution suitable for cell culture is serum separated from autologous blood, blood plasma preparation, platelet concentrated serum, plasma fraction preparation, blood protein fraction component solution, plasma expander, osmotic isotonic infusion solution. The closed cell culture system according to claim 1, which is a cell culture medium.
【請求項4】 循環させる溶液成分を治療段階ごとに変
化させることにより、欠損部の鎮痛、消毒、各再生目的
組織にとって適した細胞増殖環境を構築してプログラム
化された請求項1ないし3のいずれか1項に記載の閉鎖
型細胞培養システム。
4. The method according to claim 1, wherein the circulating solution component is changed for each treatment stage to provide analgesia of the defect, disinfection, and a cell growth environment suitable for each tissue to be regenerated and programmed. The closed cell culture system according to any one of claims.
【請求項5】 閉鎖環境に接続した回路の入口サイド
に、閉鎖環境のpH値、炭酸ガス分圧、酸素分圧を測定
するモニター装置を具備した接続したガス交換装置を組
み込み、モニター装置からの信号に基づき、ガス濃度を
自動調整して細胞培養環境を最適化する請求項1ないし
4のいずれか1項に記載の閉鎖型細胞培養システム。
5. A connected gas exchange device equipped with a monitor device for measuring pH value, carbon dioxide gas partial pressure, and oxygen partial pressure of the closed environment is installed on the inlet side of the circuit connected to the closed environment. The closed cell culture system according to claim 1, wherein the gas concentration is automatically adjusted based on the signal to optimize the cell culture environment.
【請求項6】 閉鎖環境内の圧力を持続的あるいは間欠
的に制御させた請求項1に記載の閉鎖型細胞培養システ
ム。
6. The closed cell culture system according to claim 1, wherein the pressure in the closed environment is controlled continuously or intermittently.
【請求項7】 外部に浸透圧調製済みの灌流液を灌流さ
せるための回路を設けた請求項1に記載の閉鎖型組織培
養システム。
7. The closed type tissue culture system according to claim 1, further comprising a circuit for perfusion of an osmotic pressure adjusted perfusion solution.
【請求項8】 穿刺デバイスとバルーンカテーテルの組
合せにより、体腔内深部または臓器内に細胞培養スペー
スを作る形態である請求項1または2に記載の閉鎖型細
胞培養システム。
8. The closed cell culture system according to claim 1 or 2, which has a form in which a cell culture space is formed deep inside a body cavity or in an organ by a combination of a puncture device and a balloon catheter.
【請求項9】 請求項1に記載の閉鎖型細胞培養システ
ムを利用して、灌流液中に治療薬剤を溶解させ、欠損部
位の治療を促進させる薬剤の投与方法。
9. A method for administering a drug, which utilizes the closed cell culture system according to claim 1 to dissolve a therapeutic drug in a perfusate to promote treatment of a defect site.
【請求項10】 予め自己の細胞を採取し、体外でその
細胞を培養増殖させた後に灌流液に懸濁し、灌流システ
ムを通じて閉鎖型細胞培養システムに戻し、損傷部細胞
培養の治療を行うと同時に、体外で培養した細胞を加え
ることにより、複合的に細胞培養増殖、生着を行うこと
を特徴とする損傷部の治癒を促進させる細胞の移送と増
殖方法。
10. Self-collecting cells in advance, culturing and proliferating the cells in vitro, suspending them in a perfusate, returning to a closed cell culture system through a perfusion system, and simultaneously treating the damaged cell culture. A method for transferring and proliferating cells which promotes healing of a damaged part, which comprises performing cell culture proliferation and engraftment in a complex manner by adding cells cultured in vitro.
JP2003037143A 2002-03-04 2003-02-14 Closed cell culture system Expired - Lifetime JP4067419B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003037143A JP4067419B2 (en) 2002-03-04 2003-02-14 Closed cell culture system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-57129 2002-03-04
JP2002057129 2002-03-04
JP2003037143A JP4067419B2 (en) 2002-03-04 2003-02-14 Closed cell culture system

Publications (2)

Publication Number Publication Date
JP2003325168A true JP2003325168A (en) 2003-11-18
JP4067419B2 JP4067419B2 (en) 2008-03-26

Family

ID=29713695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003037143A Expired - Lifetime JP4067419B2 (en) 2002-03-04 2003-02-14 Closed cell culture system

Country Status (1)

Country Link
JP (1) JP4067419B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008518726A (en) * 2004-11-05 2008-06-05 ブリストル−マイヤーズ スクイブ カンパニー Vacuum wound dressing
JPWO2012063725A1 (en) * 2010-11-09 2014-05-12 株式会社瑞光 Negative pressure closure therapy screen and film dressing and negative pressure closure therapy kit
CN107007891A (en) * 2016-01-27 2017-08-04 上海交通大学医学院附属第九人民医院 A kind of regenerating unit of the closed histoorgan with regeneration room

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500589A (en) * 1994-05-13 1998-01-20 ティーエイチエム・バイオメディカル・インコーポレイテッド Apparatus and method for culturing a wide variety of different tissue cells in vivo
JPH1146759A (en) * 1997-08-06 1999-02-23 Terumo Corp Cell culture fluid
WO2001006949A2 (en) * 1999-07-28 2001-02-01 Interface Biotech A/S In vitro repair of bone and/or cartilage defects
JP2001513349A (en) * 1997-08-08 2001-09-04 ツイン スター メディカル,インコーポレイティド Systems and methods for site-specific therapy
JP2001238663A (en) * 2000-03-02 2001-09-04 Takagi Ind Co Ltd Method for culturing cell or tissue and apparatus therefor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500589A (en) * 1994-05-13 1998-01-20 ティーエイチエム・バイオメディカル・インコーポレイテッド Apparatus and method for culturing a wide variety of different tissue cells in vivo
JPH1146759A (en) * 1997-08-06 1999-02-23 Terumo Corp Cell culture fluid
JP2001513349A (en) * 1997-08-08 2001-09-04 ツイン スター メディカル,インコーポレイティド Systems and methods for site-specific therapy
WO2001006949A2 (en) * 1999-07-28 2001-02-01 Interface Biotech A/S In vitro repair of bone and/or cartilage defects
JP2001238663A (en) * 2000-03-02 2001-09-04 Takagi Ind Co Ltd Method for culturing cell or tissue and apparatus therefor

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008518726A (en) * 2004-11-05 2008-06-05 ブリストル−マイヤーズ スクイブ カンパニー Vacuum wound dressing
JPWO2012063725A1 (en) * 2010-11-09 2014-05-12 株式会社瑞光 Negative pressure closure therapy screen and film dressing and negative pressure closure therapy kit
JP5868868B2 (en) * 2010-11-09 2016-02-24 株式会社瑞光 Negative pressure closure therapy screen and film dressing and negative pressure closure therapy kit
CN107007891A (en) * 2016-01-27 2017-08-04 上海交通大学医学院附属第九人民医院 A kind of regenerating unit of the closed histoorgan with regeneration room
CN107007891B (en) * 2016-01-27 2023-09-19 上海交通大学医学院附属第九人民医院 Closed tissue and organ regenerating device with tissue regenerating chamber

Also Published As

Publication number Publication date
JP4067419B2 (en) 2008-03-26

Similar Documents

Publication Publication Date Title
US7828782B2 (en) Closed cell culture system
JP5611980B2 (en) Tissue roll scaffold
JP5999713B2 (en) System and method for closing an incision
JP4555576B2 (en) Surgical device for skin treatment or examination
US20090196855A1 (en) Artificial &#34;arterio-venous&#34; permeable hollow fiber capillary system
AU2020267589B2 (en) Tissue derived porous matrices and methods for making and using same
WO2002004039A2 (en) Tube system for reconstructing of hollow organs
JP2018500106A (en) Implants for lymph node formation / regeneration
US20040037866A1 (en) Composition and method for the treatment and prevention of adhesions
JP4067419B2 (en) Closed cell culture system
JP2002501525A (en) Compositions and means for treating burns and other skin trauma
RU2757157C1 (en) Restoration of the diaphysis of long bones by cellular technology applying a method for autotransplantation of a vessel
RU2748544C1 (en) Method for targeted minimally invasive access for cell transplantation into bone regenerate
WO2021090617A1 (en) Hydrogel membrane dried product or vitrigel membrane dried product, apparatus and method for manufacturing same, and tympanic membrane treatment device and injury part treatment device
RU2777947C1 (en) Liquid in vivo bioreactor for growing bone tissue
CA3081241C (en) Medical implant for gas exchange
RU2264177C1 (en) Method for surgical treatment of renal polycystosis
RU2369335C1 (en) Method of creating artificial extrapleural cavity from intrapleural access and its stopping after extensive lung resection in case of fibrous-cavernous tuberculosis
WO2023235737A1 (en) Tunnel filler device and methods of use
JP2023124920A (en) hollow fiber bioreactor
JP5476515B2 (en) Device for administering cells
RU2369358C1 (en) Arrangement of construction of transplanted live dermal skin equivalent for treatment of bronchopleurothoracal fistulas in case of fibrous-cavernous lung tuberculosis
Gumenyuk et al. MODERN CHITOSAN-BASED WOUND DRESSINGS IN LOCAL WOUND TREATMENT: PRECLINICAL STUDIES

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20030304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20030305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20030304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20030515

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070802

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070926

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070926

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20071003

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071003

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20071228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080108

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110118

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4067419

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110118

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120118

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120118

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130118

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140118

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term